The far-reaching impact of drug discovery technology

The Drug Discovery World Podcast

Контент предоставлен Drug Discovery World and Drug Discovery World (DDW). Весь контент подкастов, включая эпизоды, графику и описания подкастов, загружается и предоставляется непосредственно компанией Drug Discovery World and Drug Discovery World (DDW) или ее партнером по платформе подкастов. Если вы считаете, что кто-то использует вашу работу, защищенную авторским правом, без вашего разрешения, вы можете выполнить процедуру, описанную здесь https://ru.player.fm/legal.

2M ago 33:52

MP3•Главная эпизода

This episode of the DDW narrated podcast series is titled “The far-reaching impact of drug discovery technology”, which covers three articles written for Volume 24 – Issue 2, Spring 2023 of DDW. They are called: “Accelerating time to market through digitalisation”, “Why digital biomarkers will power tomorrow’s Alzheimer’s therapies”, and “The path to improved safety of gene-based products”.

In the first article, Sascha Fischer Business Development Manager for Automation at Genedata looks at three critical digitalisation components that enable end-to-end lab automation, improve the return on investment (ROI) on instrumentation investments and streamline time-to-market.

In the second article, Rivka Kreitman, CIO of NeuraLight explores the landscape of therapies for Alzheimer’s and explains why digital biomarkers are key to combatting the disease.

In the third article, Kerstin Pohl, Senior Global Marketing Manager, Gene Therapy & Nucleic Acid at SCIEX, looks at the application of liquid chromatography-mass spectrometry for analysing host cell proteins.

156 эпизодов

#Drugdevelopment #Drugdiscovery #Enablingtechnologies #Healthcare #Personalisedmedicine #Pharma #Biology #Informatics #Fitness #Drug Discovery World #Biopharma #Pharmacology #Science #Medicine #Business #Therapeutics #Drug Discovery World DDW #Screen